Oct 26-30 Activities

 The following activities happened last week. 

RevGen

Metrics

Date Entry	Security	Type	Cost	Date Sold	Amount Received	Per Contract / Share Result
10/26/20	SQQQ	Oct 23 $25.00 Call	$0.21	10/26	$0.31	$0.10
10/26/20	XLF	Oct 23 $24.00 Put	$0.13	10/27	$0.15	$0.02
10/19	XLF	Oct 23 $24.00 Put	$0.09	10/22	$0.04	-$0.05
10/27	MVIS	Nov 20 $3.00 Call	0.32	10/30	0.05	-$0.27
10/28	TLT	Nov 6 $172 Call	0.11	10/30	0.06	-$0.05
10/30	INO	Nov 6 $12.50 Call	0.09	10/30	0.11	$0.02

Notes

- The SQQQ trade was a spec trade on the heavy down open on the 26th. The stop profit price was hit and sold

- Both XLF trades were technical spec trades. Both were not held long enough. Sometimes the risk level is not high enough in our trading. Profit was lost. 

- MVIS was a spec trade on earnings. It lost 

- The TLT trade was an over trading mistake and sold. 

- The INO trade was an overtrade as well and lucky to have a profit. 

KDK Fund

Metrics

Security/ Project	Type	Date of Purchase/Sale	Cost of Investment	EOW Value	Return %
Microvision	Stock	10/30/2020	$1.73	$1.73	0.00%
Microvision Nov $2.00 Call	Option	10/30/2020	-$15.00	-$16.00	-6.67%
BLOK	ETF	10/15	$25.45	$24.88	-2.24%

Notes

- We sold our position in Fuel Cell as we see an opportunity in Microvision. The sale of Fuel Cell was at $2.01, resulting in a profit of $0.21 per share. 

- We purchased shares in Microvision for $1.73 and sold calls against a portion of those shares for $0.15 per contract. We believe that Microvision is a likely takeover candidate. 

Covered Call List

- The Nov 2 Dow Component Covered Call List can be found here.  

- Any calls sold in the Oct 26th list (link here) would have expired for a full profit. 

** This blog is used for opinions and ideas and should not be used as a recommendation to act without doing your due diligence. As always, we are on Facebook, Twitter, and email through keanevcc@gmail.com**

Week's (Sept 28-Oct 2) Activities (RevGen, KDK Fund, Charity, more)

 Here are some activities from the Keane VC Consult universe. 

RevGen Trading

Metrics

Date Entry	Security	Type	Cost	Date Sold	Amount Received	Per Contract / Share Result
9/25/20	NIO	Oct 2 $23 Call	$0.07	9/29	$0.19	$0.12

Notes

- Purchased a GE Oct 30 $7.00 call for $0.16.

- Still holding IBIO Oct $5.00 call. 

KDK Fund

Metrics

Security/ Project	Type	Date of Purchase/Sale	Cost of Investment	EOW Value	Return %
Fuel Cell Energy	Stock	8/3/2020	$1.90	$2.02	6.32%
Fuel Cell Oct $3.00 Call	Option	9/21/2020	-$15.00	-$4.00	40.00%
Silvergate Bank	Stock	8/5/2020	$13.99	$14.66	4.79%
Kintara Therapeutics	Stock	8/21	$1.21	$1.52	25.62%
Microvision	Stock	9/18	$1.67	$2.03	21.56%

Notes

- There are 2 weeks remaining on the current covered call. 

Charity

- The charity made a donation to Center on Halsted. It now joins Shriners Hospitals of Chicago, Northeastern Illinois University, Illinois PPE Network, Karen Beasley Turtle Rescue as recipients of KeaneVCC charities. 

** This blog is used for opinions and ideas and should not be used as a direction to act without doing your due diligence. As always, we are on Facebook, Twitter, and email through keanevcc@gmail.com**

Week's (Sep 14-18) Metrics and Notes New Stock Purchase, Closed Covered Call

 Here is the week's activities. 

RevGen Trading

- There were no trades made last week. 

KDK Fund

Metrics

Security/ Project	Type	Date of Purchase/Sale	Cost of Investment	EOW Value	Return %
Fuel Cell Energy	Stock	8/3/2020	$2.05	$2.62	27.80%
Silvergate Bank	Stock	8/5/2020	$13.99	$15.98	14.22%
Kintara Therapeutics	Stock	8/21	$1.21	$1.50	23.97%
Microvision	Stock	9/18	$1.67	$1.76	5.39%

Notes

- The September Fuel Cell calls that were sold expired worthless. We now own the stock again and plan to sell another call next week. We are 3 for 3 in the covered call arena and plan to continue using this process to build wealth. 

- A new position in Microvision has been started. We know the company is in a moment of figuring out its direction, with a sale of part or the whole of the company likely. With over 400 patents, and being a leader in the LIDAR space, the current valuation seems low. 

Charity

- The charity will be distributing funds in the next two weeks. 

** This blog is used for opinions and ideas and should not be used as a direction to act without doing your due diligence. As always, we are on Facebook, Twitter, and email through keanevcc@gmail.com**

2020 Q2 Performance and Notes

Hello

KDK Fund is happy to report that it has had an amazing time of it since it started back on March 23rd of this year. The fund is focused on building wealth through investing available (financial, human, networking, etc.) capital to companies and projects that match its value and profit potential pillars.


Notes

- The fund currently has investments in companies that are working on providing value in the areas of Climate Change through Hannon Armstrong and Hive Blockchain, Cryptoassets (think Bitcoin and Ethereum) mining through Hive Blockchain, DNA Therapeutics through Voyager Therapeutics, Space Travel through Virgin Galactic, and an SPAC (blank check company) through Social Capital Hedosphia with a focus on non-USA tech. Previous investments included one covering Lidar, an important component in autonomous vehicles through Microvision. 

- From March 23rd, the fund has grown by 280%. There are a few reasons for this.
     - First, this quarter was the highest gaining quarter for the market since 1987. Most everyone made money if you were on the long side starting in March. This is not normal and not expected going forward.
     - Second, added funding came in from our partner KDK Options. The added volatility has increased their business. We are beneficiaries of their work as a percentage of their profits comes to the fund. Unlike the first point, we do expect higher capital funding from KDK Options going forward.
     - Third, we were able to find companies and projects to invest in that were hit hard in March, yet reached our target sell prices way sooner than expected. This allowed us to roll over the capital into other investments.

- We were also able to start the second of our investment goals; dividend paying investments supporting these initiatives. A link to that blog post can be found here.


We are expecting the rest of the year to be an accumulation period for the fund. We plan to incorporate investments that we will be able to sell call options for extra revenue by the end of the year. Good luck to all.


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Metrics and Notes from June 8-12 (Voyager Therapeutics, Virgin Galactic, more)

The following are the metrics and notes for the week of June 8-12.

Metrics

Security/ Project	Type	Date of Purchase	Cost of Investment	EOW Value	Return %
Hive Blockchain	Stock	4/16/2020	$0.22	0.26	18.18%
Social Capital	Stock	5/1/2020	$10.20	10.98	7.65%
Hannon Armstrong	Stock	6/5/2020	30.76	28.27	-8.09%
Microvision	Stock	5/18	$0.93	1.1	18.28%
Virgin Galactic	Stock	6/8	$16.82	14.99	-10.88%
Voyager Therapeutics	Stock	6/11	$12.25	12.13	-0.98%

Notes

Virgin Galactic (story link here) and Voyager Therapeutics (story link here) are new additions to the fund.

Hannon Armstrong announced their quarterly dividend. The story link is here. 

Hive Blockchain has increased its hash rate and mining efficiency. The Yahoo! story link is here.

The fund now has investments mostly covering Climate Change, Blockchain, Cryptocurrency, DNA Therapeutic Research, Exploration, Lidar, and US based Tech. 


**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

May 18 - 22 Performance (IBio Inc., Microvision, Fuel Cell Energy, more)

Here are some metrics and notes for the fund's activity during May 18 - 22.

Security/ Project	Type	Date of Purchase	Cost of Investment	Current Value	Return %
Hive Blockchain	Stock	4/16/2020	$0.16	0.26	62.50%
Social Capital	Stock	5/1/2020	$10.20	10.6	3.92%
Fuel Cell Energy	Stock	5/3	$2.01	1.98	-1.49%
Microvision	Stock	5/18	$0.93	0.98	5.38%

- The fund sold its stock in IBio as the value of the investment increased over 60%.

- A position has been started in Microvision again at $0.93. A link to the story is here.
- More shares of Fuel Cell Energy have been purchased.



**All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.

Portfolio Weekly Performance (Crispr, Microvision, Hive Blockchain, Social Capital)

Here are some metrics and some activity notes.

Security/Project	Type	Date of Purchase	Cost of Investment	Current Value	Return %	Notes
Crispr Therapeutics	Stock	3/23/2020	$38.78	54.01	39.27%
Microvision	Stock	3/23/2020	$0.00	0.44	100.00%	Sold Cost portion. All Profit at this point
Hive Blockchain	Stock	4/16/2020	$0.16	0.23	43.75%
Social Capital	Stock	5/1/2020	$10.20	10.19	-0.10%

- Crispr released earnings this past week. Story link can be found here.
- Sold 1/2 of Microvision stock. Story here.
- Microvision releasing earnings this week. 
- Bought Social Capital. Story here. 



 **All posts on this blog are information and opinions only. They are not to be considered recommendations to buy or sell any security. Please do your due diligence first before trading and investing. Please direct all questions and comments to the blog, kdkfund@gmail.com, or on twitter @kdkfund.